Wealthedge Investment Advisors LLC Invests $965,000 in Vertex Pharmaceuticals Incorporated $VRTX

2026-03-08 04:03:51

Wealthedge Investment Advisors LLC recently acquired a new stake of 2,465 shares in Vertex Pharmaceuticals (VRTX) worth $965,000 during the third quarter, contributing to institutional ownership of approximately 90.96% of the stock. Despite a slight EPS miss in Q4, the company reported increased revenue, and analysts maintain a “Moderate Buy” rating with a target price of $542. However, recent clustered insider selling, notably by EVP Amit Sachdev, may introduce near-term negative sentiment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes